TRIM32 promotes proliferation and confers chemoresistance to breast cancer cells through activation of the NF-κB pathway

Dysregulation of TRIM32 has been implicated in several human cancers, however, its clinical significance and biological function in breast cancer have not been investigated. Using immunohistochemistry, we found that TRIM32 expression is upregulated in breast cancer tissues and that it correlates wit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Cancer
Main Authors: Zhao, Ting-Ting, Jin, Feng, Li, Ji-Guang, Xu, Ying-Ying, Dong, Hui-Ting, Liu, Qun, Xing, Peng, Zhu, Guo-Lian, Xu, Hao, Yin, Song-Cheng, Miao, Zhi-Feng
Formato: Artigo
Idioma:Inglês
Publicado em: Ivyspring International Publisher 2018
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5929078/
https://ncbi.nlm.nih.gov/pubmed/29721043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.22390
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados